Literature DB >> 22556006

Does the Addenbrooke's Cognitive Examination-revised add to the Mini-Mental State Examination in established Alzheimer disease? Results from a national dementia research register.

Emma Law1, Peter J Connelly, Emma Randall, Catriona McNeill, Helen C Fox, Mario A Parra, Justine Hudson, Leigh-Ann Whyte, Jane Johnstone, Sarah Gray, John M Starr.   

Abstract

OBJECTIVE: To evaluate how much the Addenbrooke's Cognitive Examination-revised (ACE-R) improves the estimate of cognitive ability from the Mini-Mental State Examination (MMSE) in people with Alzheimer disease (AD).
METHODS: We examined itemized data in people with AD who were on the Scottish Dementia Research Interest Register drawn from eight centres across Scotland, covering 75% of the Scottish population. ACE-R items that comprise the MMSE and those that did not (non-MMSE items) were summed separately. We residualized MMSE total on non-MMSE total and vice versa to derive a measure of the variance unique to each.
RESULTS: Five hundred and one (258 male, 243 female) participants, mean age 75.7 (range 52-94) years were on the register, of whom 329 (160 men, 169 women) had AD. Of those with AD, 309 had a mean MMSE of 20.5 and mean ACE-R of 57.5 measured with Pearson r = 0.92 between MMSE and ACE-R totals, and the regression equation ACE-R score = 3.0 × MMSE - 4.1. The unique non-MMSE items score correlated with ACE-R total r = 0.40 (16% of ACE-R variance).
CONCLUSIONS: The ACE-R and MMSE total scores are highly correlated. In this clinical sample of people with established AD, for an MMSE score of 24, the predicted ACE-R score was 67.9 with 95% confidence intervals of 61.6-75.4. The extra non-MMSE ACE-R items improve estimates of cognitive ability by 16%.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22556006     DOI: 10.1002/gps.3828

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  5 in total

1.  Thought-feeling discrimination in people with dementia: adaptation and preliminary validation of the first dementia-specific measure.

Authors:  Joshua Stott; Tim Cadman; Henry Potts; Katrina Scior; Janina Brede; Georgina Charlesworth
Journal:  Int Psychogeriatr       Date:  2020-01       Impact factor: 3.878

2.  Effectiveness of an intervention to facilitate prompt referral to memory clinics in the United Kingdom: Cluster randomised controlled trial.

Authors:  Gill Livingston; Gianluca Baio; Andrew Sommerlad; Simon de Lusignan; Spyridon Poulimenos; Steve Morris; Greta Rait; Juanita Hoe
Journal:  PLoS Med       Date:  2017-03-14       Impact factor: 11.069

3.  The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy.

Authors:  Bei Cao; Bi Zhao; Qian-Qian Wei; Ke Chen; Jing Yang; RuWei Ou; Ying Wu; Hui-Fang Shang
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

4.  A protocol for precise comparisons of small vessel disease lesions between ex vivo magnetic resonance imaging and histopathology.

Authors:  Catherine A Humphreys; Maurits A Jansen; Susana Muñoz Maniega; Víctor González-Castro; Cyril Pernet; Ian J Deary; Rustam Al-Shahi Salman; Joanna M Wardlaw; Colin Smith
Journal:  Int J Stroke       Date:  2018-09-10       Impact factor: 5.266

5.  Reorganization of brain networks and its association with general cognitive performance over the adult lifespan.

Authors:  Epifanio Bagarinao; Hirohisa Watanabe; Satoshi Maesawa; Daisuke Mori; Kazuhiro Hara; Kazuya Kawabata; Noritaka Yoneyama; Reiko Ohdake; Kazunori Imai; Michihito Masuda; Takamasa Yokoi; Aya Ogura; Toshiaki Taoka; Shuji Koyama; Hiroki C Tanabe; Masahisa Katsuno; Toshihiko Wakabayashi; Masafumi Kuzuya; Norio Ozaki; Minoru Hoshiyama; Haruo Isoda; Shinji Naganawa; Gen Sobue
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.